Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating ...

Pending regulatory authorization, Fractyl expects to dose the first patients with RJVA-001 and report preliminary data in 2026, which the Company believes could lead to a potentially first-in-class, ...

In both children and adults, the drug allows for decreasing glucocorticoid dosing to physiological levels while still ...

Our Bureau, Mumbai Monday, May 12, 2025, 14:45 Hrs [IST] ...

Upadacitinib shows sustained efficacy and consistent safety for moderate to severe ulcerative colitis in long-term trials and ...

Positive phase 3 results from the CAN-2409 clinical trial in intermediate-to-high risk localized prostate cancer have been ...

This includes VoiceOver, Voice Control, Larger Text, Sufficient Contrast, Reduced Motion, and captions. Accessibility Nutrition Labels will be ... users can easily open any app by typing with ...

The new Accessibility Nutrition Labels will show users which accessibility features an app supports before downloading it. This includes VoiceOver, Voice Control ... can easily open any app ...

Bill, also known as the UK data protection reform, came back to the House of Lords for what was supposed to be its final ...

Q1 2025 Earnings Call Transcript May 13, 2025Fractyl Health, Inc. Common Stock reports earnings inline with expectations.

Apple is set to unveil iOS 19 at WWDC 2025. Ahead of the developer’s conference, the company has confirmed a slew of ...